EN DE
STOCK COMPARISON

Cathay Biotech vs Nigbas Nigde Beton Sanayi ve Ticaret AS: Fair Value & Quality

Both stocks run through our valuation models. Here is how Cathay Biotech (688065) and Nigbas Nigde Beton Sanayi ve Ticaret AS (NIBAS) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees Nigbas Nigde Beton Sanayi ve Ticaret AS as the less overvalued of the two: Cathay Biotech trades at ¥48.95 versus a fair value of ¥11.33 (-77%), while Nigbas Nigde Beton Sanayi ve Ticaret AS trades at TRY 3.80 versus TRY 2.85 (-25%).
Cathay Biotech
688065.SHG · CNY · Materials
-77%
upside to fair value
overvalued
Price¥48.95
Fair Value¥11.33
Quality34/100
Nigbas Nigde Beton Sanayi ve Ticaret AS
NIBAS.IS · TRY · Industrials
-25%
upside to fair value
overvalued
PriceTRY 3.80
Fair ValueTRY 2.85
Quality26/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Cathay BiotechNigbas Nigde Beton Sanayi ve Ticaret AS
Valuation
55.1×P/E (TTM)—
9.61×P/S (TTM)0.22×
1.54×P/B0.06×
26.0×EV/EBITDA1.3×
1.0%Dividend yield—
¥0.45Dividend per share—
Profitability
17%Net margin0%
24%Operating margin-12%
3%Return on equity-73%
2%Return on assets0%
Growth
13%Revenue growth (YoY)72%
10.5%Avg. growth/yr (3Y)18.8%
17.1%Avg. growth/yr (5Y)31.5%
Balance & size
0.01×Debt / equity—
$5BMarket cap$25M
expensiveGrowth qualityexpensive

Nigbas Nigde Beton Sanayi ve Ticaret AS leads: 4 to 6 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Cathay Biotechof which business quality 38 · market factors 47 Nigbas Nigde Beton Sanayi ve Ticaret ASof which business quality 30 · market factors 24
ProfitabilityMargins and returns on capital today
26
4
Quality GrowthAre margins and returns improving?
36
76
CashflowEarnings quality: real cash, not paper profit
16
0
Fin. StrengthBalance sheet, leverage, solvency risk
100
63
InvestmentDisciplined investing over empire-building
16
3
Low VolatilityCalm price path (market factor)
72
50
MomentumPrice trend over the last 3–12 months (market factor)
35
20
52W MomentumDistance to the 52-week high (market factor)
40
3
Net IssuanceBuybacks instead of dilution
13
40

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Cathay Biotech

DCF Models¥17.30
Earnings-Based¥15.77
Dividend Discount¥7.64
Multiples¥16.38
Asset-Based¥19.71
Economic Profit¥20.96
Growth Earnings¥14.07

17 of 17 models see the stock below the current price.

Nigbas Nigde Beton Sanayi ve Ticaret AS

Earnings-BasedTRY 2.07
Dividend DiscountTRY 0.52
MultiplesTRY 2.85
Asset-BasedTRY 22.28
Economic ProfitTRY 2.07

6 of 8 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Cathay Biotech
Bear ¥8.50Fair Value ¥11.33Bull ¥15.55
¥48.95 = current price (white tick)
Nigbas Nigde Beton Sanayi ve Ticaret AS
Bear TRY 1.90Fair Value TRY 2.85Bull TRY 3.80
TRY 3.80 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Cathay Biotech · Materials

Quality score34 · bottom 25%
Fair value upside-77% · bottom 25%

Nigbas Nigde Beton Sanayi ve Ticaret AS · Industrials

Quality score26 · bottom 25%
Fair value upside-25% · below median

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees Nigbas Nigde Beton Sanayi ve Ticaret AS as the less overvalued of the two: Cathay Biotech trades at ¥48.95 versus a fair value of ¥11.33 (-77%), while Nigbas Nigde Beton Sanayi ve Ticaret AS trades at TRY 3.80 versus TRY 2.85 (-25%).

Cathay Biotech has the higher quality score (34/100).

See the full analysis →
Cathay Biotech · Nigbas Nigde Beton Sanayi ve Ticaret AS

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Cathay Biotech

Alphabet Inc Class C vs Verizon CommunicationsAlphabet Inc Class C vs At&tAlphabet Inc Class C vs NetEaseAmazon.com vs Toyota Motor Corporation

Related to Nigbas Nigde Beton Sanayi ve Ticaret AS

Amazon.com vs PDD HoldingsAmazon.com vs Sony GroupMeta Platforms vs Verizon CommunicationsMeta Platforms vs At&t
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.